Quality　Indicator　2012[医療の質]を測り改善する

出版社： インターメディカ
著者：
発行日： 2012-10-10
分野： 医学一般  >  制度(法/経済)
ISBN： 9784899963028
電子書籍版： 2012-10-10 （初第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

3,300 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

3,300 円(税込)

購入する

商品紹介

QIを測定・公表する病院が急増！　聖路加国際病院の8年間の試みが、今、多くの病院で医療の質改善の一助に！

目次

  • Quality Indicator 2012［医療の質］を測り改善する

    ―目次―

    第1章　 医療の質とEBM、Quality Indicator
    第2章　 聖路加国際病院におけるQI測定・公表の
    　　　　　経緯・手順と「改善」
    第3章　 病院全体
    第4章　 報告・記録
    第5章　 教育
    第6章　 患者満足
    第7章　 看護
    第8章　 薬剤
    第9章　 手術・処置
    第10章　生活習慣
    第11章　呼吸器
    第12章　脳・神経
    第13章　心血管
    第14章　慢性腎臓病
    第15章　消化器
    第16章　眼・耳鼻咽喉
    第17章　救急
    第18章　がん・腫瘍
    第19章　地域連携

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 医療の質とEBM、 Quality Indicator

P.15 掲載の参考文献
1) Donabedian A:Evaluating the quality of medical care. Milbank Memorial Fund Quarterty 1966;44:166-206.
 
2) Fletcher RH, et al:Clinical Epidemiology:The Essentials. 4th ed. Lippincott Williams & Wilkins, Baltimore, 2005 (福井次矢 (監訳) . メディカル・サイエンス・インターナショナル, 2006) .
 
3) Lohr KN (ed) . Medicine:A strategy for quality assurance. Vols I and II. Washington DC:National Academy Press, 1990.
 
4) Medical Milestones:Celebrating key advances since 1840. British Medical Journal 2007;334:s10.
 
5) Mainz J:Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003;15:523-530.
PubMed
6) Ader M, et al:Quality Indicators for health promotion programmes. Health promotion International 2001;16:187-195.
PubMed
7) Guthrie B, et al:Tackling therapeutic inertia:role of treatment data In quality indicators. BMJ 2007;335:542-544.
PubMed
8) Campbell SM, et al.:Improvements in Quality of clinical care in England general practice 1998-2003:longitudinal observational study. BMJ 2005;331:1121-1123.
PubMed
9) Rollow W, et al:Assessment of the medicare quality improvement organization program. Ann Intern Med 2006;145:342-352.
PubMed
10) 2009年度厚生労働省科学研究費補助金 (地域医療基盤開発推進研究事業) 「医療の質向上に資するアウトカム評価に関する研究」 (研究代表者:福井次矢), 2010年5月.
 

第3章 病院全体

P.45 掲載の参考文献
1) 平成23年病院運営実態分析調査の概要;全国公私病院連盟社団法人日本病院会 (平成24年3月28日) http://www005.upp.so-net.net.ne.jp/byo-ren/H23-gaiyou.doc (2012.06.12 available)
 
P.47 掲載の参考文献
1) 厚生労働省 平成19年労働者健康状況調査.
 
P.48 掲載の参考文献
1) Britton J, et. al:Tobacco smoking, harm reduction, and nicotine product regulation. Lancet 2008;371:441-445.
 
2) Oberg M, et. al:Worldwide burden of disease from exposure to second-hand smoke:a retrospective analysis of data from 192 countries. Lancet 2011;377(9760):139-146.
 
3) 厚生労働省 平成20年国民健康・栄養調査.
Medical*Online
P.50 掲載の参考文献
1) CDC. Prevention and Control of Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR 56:No. RR-8.
 
2) 独立行政法人 国立病院機構本部臨床評価指標 2009. http://www.hosp.go.jp/resources/content/7018/ci2009.pdf (2012.05.18 available)
 
P.52 掲載の参考文献
1) 平成16年度 (2004年度) 日本内科学会認定医制度 教育病院・大学病院年報 (教育病院415施設・大学病院80施設) .
 
P.55 掲載の参考文献
1) トヨタ記念病院:病院実績・臨床指標医療スタッフに関する指標. http://www.toyota-mh.jp/about/qi/shihyou6.html (2012.06.25 availale)
 
P.56 掲載の参考文献
1) 上原鳴夫, 黒田幸清他:医療の質マネジメントシステム, 日本規格協会, 2003.
 
2) 井部俊子, 中西睦子監修:看護管理学習テキスト第2版看護経営・経済論, 日本看護協会出版会, 2011.
 
3) 看護データバンク, EBNURSING増刊1号, 中山書店, 2010.
 
4) 厚生の指標 増刊, 国民衛生の動向 2011/2012, 財団法人 厚生統計協会, 2011.
 
5) 平成23年病院運営実態分析調査の概要:全国公私病院連盟 社団法人日本病院会 (平成24年3月28日) http://www005.upp50-net.ne.jp/byo-ren/H23-gaiyou.doc (2012.05.17 available)
 
P.59 掲載の参考文献
1) 厚生労働省「再入院の状況について」. http://www.mhlw.go.jp/stf/shingi/2r9852000001u23a.html (2012.05.07 available)
 

第4章 報告・記録

P.65 掲載の参考文献
1) The Australian Council on Healthcare Standards:ACHS Australasian Clinical Indicator Report:2003-2010 Determining the Potential to Improve Quatity of Care:12th Edition. http://www.achs.org.au/pdf/Radiology_www.pdf(2012.05.07 available)
 
P.67 掲載の参考文献
1) The Australian Council on Healthcare Standards:ACHS Australasian Clinical Indicator Report:2003-2010 Determining the Potential to Improve Quality of Care:12th Edition. http://www.achs.org.au/pdf/Pathology_www.pdf (2012.05.07 available)
 

第5章 教育

P.73 掲載の参考文献
1) Nakhteh RE, et al:Autopsy Result Utitization A College of American Pathologists Q-Probes Study of 256 Laboratories. Arch Pathol Lab Med 1999;123:290-295.
 
P.74 掲載の参考文献
1) 平成18年度「臨床研修に関する調査」報告の概要 (平成19年9月6日) http://www.mhlw.go.jp/topics/bukyoku/isei/rinsyo/chosa-saisyu06/dl/01b.pdf(2012.05.07 available) http://www.niph.go.jp/soshiki/jinzai/kenshu-gl/pdf/1/1syou_4.pdf (2012.05.07 available)
 
P.76 掲載の参考文献
1) 医師臨床研修マッチング協議会 平成22年度都道府県毎第一希望マッチ者数. http://www.jrmp.jp/rol/2010rol.pdf (2012.05.07 available)
 
P.79 掲載の参考文献
1) 厚生の指標増刊, 国民衛生の動向 2011/2012, 財団法人 厚生統計協会, 2011.
 
2) 日本看護系大学協議会 http://www.janpu.or.jp
 
3) 日本看護協会編:平成23年版看護白書, 日本看護協会出版会, 2011.
 
4) U.S. Department of Health and Human Services Health Resources and Services Administration;Findings from the 2008 National Sample Survey of Registered Nurses:The Registered Nurse Population. http://thefutureofnursing.org/sites/default/files/RN%20Nurse%20Population.pdf (2012.05.08 available)
 
P.82 掲載の参考文献
1) 日本看護協会ホームページ http://www.nurse.or.jp/nursing/qualification/howto/index.html
 
2) 日本看護協会編:平成23年版看護白書, 日本看護協会出版会, 2011.
 
3) 厚生の指標増刊, 国民衛生の動向 2011/2012. 財団法人厚生統計協会, 2011.
 

第6章 患者満足

P.89 掲載の参考文献
1) 前田泉, 徳田茂二著:患者満足度コミュニケーションと受療行動のダイナミズム, 日本評論社, 2003.
 

第7章 看護

P.92 掲載の参考文献
1) Healey F, Scobie S, Glampson B, Pryce A, Joule N, Willmott M:Slips, trips and falls in hospital London:NHS 2007;1.
 
P.96 掲載の参考文献
1) 厚生労働科学研究費補助金事業 (医療安全・医療技術評価総合研究事業) 平成16-18年度「医療安全のための教材と教育方法の開発に関する研究」班研究報告書 別冊「転倒・転落対策のガイドライン」 (主任研究者:上原鳴夫).
 
2) Healey F, Scobie S, Glampson B, Pryce A, Joute N, Willmott M:Slips, trips and falls in hospital London:NHS2007;1.
 
3) Montalvo I:The National Database of Nursing Quality Indicators TM (NDNQI(R)). Ojin:The Online Journal of Issues in Nursing 2007;12.
 
P.99 掲載の参考文献
1)「看護ケアの質の評価基準に関する研究」:1993年文部科学研究, 主任 研究者片田範子.
 
2) American Nurses Credentialing Center:Magnet Recognition Program, 2005.
 
3) The Australian Council on Healthcare Standards:ACHS Australasian Clinical Indicator Report:2001-2008 Determining the Potential to Improve Quality og Care :10th Edition. http://www.achs.org.au/pdf/temp//Australasian_Clinical_Indicator_Report_200108_10thEdition.pdf (2011.04.25 available)
 
4) 厚生労働省平成22年度医療の質の評価・公表等推進事業実施団体: (社) 日本病院会. http://www.hospitalor.jp/pdf/06_20110428-01.pdf (2012. 05. 07available)
 
5) The Joint Commission;The Implementation Guide forthe NQF Endorsed Nursing-Sensitive Care Measure Set 2009, version 2.0. http://www.jointcommission.org/assets/1/6/NSC%20Manua.pdf (2011.03.31 available)
 
6) European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel; Pressure Ulcer Prevention:Quik Reference Guide. http://www.npuap.org/Final_Quick_Prevention_for_web_2010.pdf (2011.03.31 available)
 
7) 日本褥瘡学会編:褥瘡予防・管理ガイドライン. http://minds.jcqhc.or.jp/stc/0036/1/0036_G0000181_GL.html (2011.03.31 available)
 
P.101 掲載の参考文献
1) 日本褥瘡学会編:褥瘡予防・管理ガイドライン. http://minds.jcqhc.or.jp/stc/0036/1/0036_G0000181_GLhtml (2011. 03. 31 avaitabte)
 
P.102 掲載の参考文献
1) 迫田綾子:摂食・嚥下障害患者への口腔ケア. 臨床看護2009;35 (4):518-527.
 
2) 大西徹郎他:口腔ケアのチームアプローチとそのシステム. 看護技術 2008. 12;54 (14).
 
3) 財団法人8020推進財団 口腔と全身の健康状態に関する文献調査報告書 (I). http://www.8020zaidan.or.jp/
 
4) 木野毅彦他監修:口腔ケアの達人になる (. 看護ジャーナル2011;5:28-41.
 
5) 井村久美子:口腔ケアは, VAPを減らすの?. EBnursing 2010;10 (1):32-33.
Medical*Online
6) ヴァージニア・ヘンダーソン著, 湯槇ます・児玉香津子訳:看護の基本となるもの. 日本看護協会出版会, 2006.
 

第8章 薬剤

P.108 掲載の参考文献
1) The Australian Council on Healthcare Standards:ACHS Australasian Clinical Indicator Report:2003-2010 Determining the Potential to lmprove Quality of Care:12th Edition. http://www.achs.org.au/pdf/AdverseDrugReaction_www.pdf (2012.05.22 available)
 
2) Baker WL, Cios DA, Saunder SD, et al.:Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm 2009;15:244-252.
 
3) Singer DE, Albers GW, Dalen JE, et al:Antithrombotictherapy in atrial fibrillation:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133 (6 Suppl):546S-592S.
 
4) 循環器病の診断と治療に関するガイドライン (2002-2003年度合同研究班報告) . 循環器疾患における抗凝固・抗血小板療法に関するガイドライン:Jpn Cir J 2004;68(Suppl IV):1153-1219.
 
P.111 掲載の参考文献
1) 厚生統計協会編:『国民衛生の動向 2003年 (『厚生の指標』臨時増刊 (第50巻第9号)) 』. 厚生統計協会, 2003.
 
2) Ensrud KE, Thompson DE, Cauley JA, et al:Prevalent vertebral deformities predict mortatity and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 2000;48 (3):241-249. PubMed PMID:10733048.
 
3) Lu-Yao GL, Baron JA, Barrett JA, et al.:Treatment and survival among elderly Americans with hip fractures:a population-based study. Am J Public Health 1994:84 (8):1287-1291. PubMed PMID:8059887; PubMed Central PMCID:PMC1615444.
 
4) Roux C, Seeman E, Eastell R, et al:Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin 2004;20 (4):433-439. PubMed PMID:15119979.
 
5) Grossman JM, Gordon R, Ranganath Vk et al:American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010;62 (11):1515-1526.doi:10.1002/acr.20295.Epub 2010 Jul 26. Review.PubMed PMID:20662044.
 
6) Daniel HS, Jeffrey NK, Jonathan PJ, et al:Management of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatoid Arthritis. ARTHRITIS & RHEUMATISM 2002, Vol 46, No. 12, 3136-3142, DOI 10.1002/art.10613.
 
P.113 掲載の参考文献
1) 恩田光子, 小林暁峯, 黒田和夫他:薬剤管理指導が患者アウトカムに与える効果に関する研究. 医療マネジメント学会雑誌2004;5:349-353.
 
2) 恩田光子, 小林暁峯, 黒田和夫他:薬剤管理指導業務が臨床アウトカムに与える影響に関する研究. 病院管理2004;41 (4):255-262.
 
3) Chisholm-Burns MA, Kim Lee J, Spivey CA, et al:US pharmacists' effect as team members on patient care:systematic review and meta-analyses. Med Care 2010; 48(10):923-933. Review. PubMed PMID:20720510.
 
4) 木幡華子, 計良貴之, 田中恒明他:薬剤師の病棟配置が薬物療法の質および医療安全に与える影響. 日本病院薬剤師会誌2012:48 (2):173-176.
 
5) 日本病院薬剤師会総務部:平成21年度「病院薬剤部門の現状調査」集計結果報告. 日本病院薬剤師会誌 2010;46 (9):1173-1215.
 

第9章 手術・処置

P.117 掲載の参考文献
1) McGee DC, Gould MK:Preventing Complications of Central venous catheterization. N Engl J Med 2003;348:1123.
PubMed
2) Graham AS, 0zment C, et al.:Videos in clinical medicine. central venous catheterization. N Engl J Med 2007;356:e21.
 
3) GHind D, Calvert N, McWilliams R, et al:Ultrasonic locating devices for central venous cannulation:meta-analysis. BMJ 2003;327:361.
PubMed
P.119 掲載の参考文献
1) The Austratian Council on Healthcare Standards:ACHS Australasian Clinical Indicator Report:2003-2010 Determining the Potential to Improve Quality of Care:12th Edition. http://www.achs.org.au/pdf/Anaesthesia_www.pdf (2012.05.07 available)
 
P.121 掲載の参考文献
1) Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ:The impact of surgical-site infections in the 1990s:attributable mortality, excess length of hospitalization, and extra costs. Infect Controt Hosp Epidemiol 1999;20;725-730.
 
2) CDC:Guideline for the Prevention of Surgical Site Infection, 1999. Infect Cont Hosp Epidemiol 1999;20:247-278.
 
3) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c SCIP-Inf-1 Prophylactic Antibiotic Received Within 0ne Hour Prior to Surgical Incision. http://www.jointcommission.org/assets/1/6/NHQM_v4_0_5c_pdf_12_29_2011.zip (2012.05.28 available)
 
4) 福井次矢監修:Quality Indicator 2011聖路加国際病院の先端的試み [医療の質]を測り改善する:p.102-103, インターメディカ, 2011.
 
5) The Joint Commission; Improving America's Hospitals The Joint Commission's Annual Report on Quality and Safety 2011. http://www.jointcommission.org/assets/1/6/TJC_Annual_Report_2011_9_13_11_.pdf (2012. 05. 28 available)
 
P.123 掲載の参考文献
1) Sakuma M, Nakamura M, Yamada N, et al:Venous thromboembotism-Deep vein thrombosis with pulmonary embotism, deep veinthrombosis atone, pulmonary embolism atone. Circ J 2009;73:305-309.
 
2) Nakamura M, Fujioka H, Yamada N, et al.:Clinical chararteristics of acute pulmonary thromboembolism in Japan:results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol 2001;24:132-138.
PubMed
3) 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会:肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン. Medicat Front Internationat Limited, 東京, 2004.
 
4) 古家仁, 瀬尾憲正, 北口勝康他:社団法人日本麻酔科学会周術期肺塞栓症調査2005年結果 (短報). Therapeutic research 2008;29:659-661.
Medical*Online
5) The Joint Commission; Improving America's Hospitals The Joint Commission's Annual Report on Quality and Safety 2011. http://www.jointcommission.0rg/assets/1/6/TJC_Annual_Report_2011_9_13_11_pdf (2012.05.28 available)
 
6) The Joint Commission;Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0 c SCIP-VTE-2 Surgery Patients Who Received Appropriate Venous Thromboembolism Prophylaxis Within 24 Hours Prior to Surgery to 24 Hours After Surgery. http://www.jointcommission.org/assets/1/6/NHQM_v4_0_C_pdf_12_29_2011.zip (2012.05.28 available)
 
P.125 掲載の参考文献
1) Sakuma M, Nakamura M, Yamada N, et al.:Venous thromboembolism-Deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, pulmonary embolism alone. Circ J 2009;73:305-309.
PubMed
2) Nakamura M, Fujioka H, Yamada N, et al.:Clinical characteristics of acute pulmonary thromboembolism in Japan:results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol 2001;24:132-138.
PubMed
3) 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会. 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン. Medical Front International Limited, 東京, 2004.
 
4) 社団法人日本病院会平成22年度医療の質の評価・公表等推進事業結果報告. http://www.hospital.or.jp/pdf/06_0110428_01.pdf (2012.05.28 available)
 
5) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c VTE-6 Incidence of Potentially-Preventable Venous Thromboembolism. http://www.jointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012. 05.28 available)
 
P.127 掲載の参考文献
1) Moslem-Kebria M, El-Nashar SA, Atetti GD et al.:Intraoperative Hypothermia during Cytoreductive Surgery for 0varian Cancer and Perioperative Morbidity. Obstet Gynecol 2012;119:590-596.
 
2) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c SCIP-Inf-10 Surgery Patients with Perioperative Temperature Management http://www.jointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012. 05. 20 availale)
 
3) Kurz A, Sessler DI, Lenhardt R:Perioperative Normothermia to Reduce the Incidence of Surgical-wound Infection and Shorten Hospitalization, Study of Wound Infection and Temperature Group. N Engl J Med 1996;334:1209-1215.
 
4) Frank SM, Fteisher LA, Brestow MJ et al:Perioperative Maintenance of Normothermia Reduces the Incidence of Morbid Cardiac Events. A Randomized Clinical Trial JAMA 1997;277:1127-1134.
 
5) Schmied H, Kurz A, Sesster DI et al:Mild Hypothermia Increases Blood Loss and Transfusion Requirements during Total Hip. Lancet 1996;347:289-292.
 
P.129 掲載の参考文献
1) Kirkland KB, Briggs JP, Trivette SL, Witkinson WE, Sexton DJ:The impact of surgicat-site infections in the 1990s:attributabte mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725-730.
 
2) CDC:Guideline for the Prevention of Surgical Site lnfection, 1999. Infect Cont Hosp Epidemiol 1999;20:247-278.
 
3) Bratzler DW, Houck PM:Antimicrobial prophylaxis for surgery:an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38 (12):1706-1715. Epub 2004 May 26. Review. PubMed PMID:15227616.
 
4) Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR:Society of Thoracic Surgeons. The Society of Thoracic Surgeons Practice Guideline Series:Antibiotic Prophylaxis in Cardiac Surgery, Part I:Duration. Ann Thorac Surg 2006;81 (1):397-404. PubMed PMID:16368422.
 
5) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c SCIP-Inf-3 Prophylactic Antibiotic Discontinued Within 24 Hours After Surgery End Time (48 hours for CABG or Other Cardiac Surgery). http://wwww.jointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012. 05. 28 available)
 
6) 福井次矢監修:Quality Indicator 2011 聖路加国際病院の先端的試み [医療の質]を測り改善する.Pp109-111, インターメディカ, 2011.
 
7) The Joint Commission; Improving America's Hospitals The Joint Commission's Annual Report on Quality and Safety 2011 http://www.jointcommission.org/assets/1/6/TJC_Annual_Report_2011_9_13_11-.pdf (2012. 05. 28available)
 

第10章 生活習慣

P.133 掲載の参考文献
1) Agency for Healthcare Research and Quality. National Quality Measures Clearinghouse:Diabetes mellitus:percent of patients with 2 HbA1c's in the last year (at least 3 months apart). http://www.qualitymeasures.ahrq.gov/content.aspx?id=16885 (2012. 05.07 available)
 
P.134 掲載の参考文献
1) U.S. Department of Health and Human services Agency for Healthcare Research and Quality:National Health Care Quality & Disparities Report. http://nhqrnet.ahrq.gov/nhqrdr/jsp/nhqrdr.jsp#snhere#snhere (2012. 05. 07available)
 
2) U.S. Department of Health and Human Services Agency for Healthcare Research and Quality:2011 National Healthcare Quality Report. http://www.ahrq.gov/qual/nhqr11/nhqr11.pdf (2012. 05. 07 available)
 
P.137 掲載の参考文献
1) Hypertension:algorithm for measures calculation:EHRS. Version 3.0. Chicago, III:American Medical Association. 2006.
 
2) Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al.:Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42 (6):1206-1252. doi:10.1161/01.HYP.0000107251.49515.c2.
 
3) American Medical Association. HYPERTENSION (HTN) Algorithm for Measures calculation-EHRS (Analytic Narrative and Data Elements). http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/htnanalyticnarr307_7.pdf (2012.05.20 avaliable)
 
P.139 掲載の参考文献
1) Thom T, Haase N, Rosamond W, Howard VJ, Rumsfetd J, Manotio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P:American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2006 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113 (6):e85-151. Epub 2006 Jan 11. Erratum in:Circulation 2006 Dec5; 114 (23):e630. Circulation 2006 Apr 11;113 (14):e696.
 
2) Psaty BM, Manolio T, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, et al.:Time trends in high blood pressure control and the use of antihypertensive medications in older adults:the Cardiovascular Health Study. Archives of internal medicine 2002;162 (20):2325-2332. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12418946.
 
3) Turnbull F:Effects of different blood-pressure-lowering regimens on major cardiovascular events:results of prospectively-designed overviews of randomised trials. Lancet 2003;362 (9395):1527-1535. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14615107.
 
4) Turnbull F, Neal B, Pfeffer M, Kostis J, Algert C, Woodward M, et al.:Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. Journal of hypertension 2007;25 (5):951-958. doi:10. 1097/ HJH.0b013e3280badgb4.
 
5) 高血圧治療ガイドライン2009.
 
6) Julius S, Kjeldsen S. E, Weber M, Brunner H. R, Ekman S, Hansson L, et al.:Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine:the VALUE randomised trial. Lancet 2004; 363 (9426):2022-2031. doi:10. 1016/S0140-6736 (04) 16451-9.
 
7) NHS Employers Quality and 0utcomes Framework guidance for GMS contract 2011/12 Delivering investment in general practice April 2011. http://www.nhsemployers.org/Aboutus/Publications/Documents/QOF_guidance_GMS_contract_2011-12.pdf (2012.05.21 available)
 
P.142 掲載の参考文献
1) Person TA, et al.:The Lipid Treatment Assessment Project (L-TAP):A Multicenter Survey to Evaluate the Percentages of Dyslipidemic Patients Receiving Lipid-Lowering Therapy and Achieving Low-Density Lipoprotein Cholesterol Goals. Arch Intern Med 2000; 160:459-467.
 
2) Teramoto T, et al. for the J-LAP investigators:Status of Lipid-lowering therapy prescribed based on recommendations in the 2002 report of the Japan Atherosclerosis Society Guideline for diagnosis and treatment of hyperlipidemia in Japanese adults:a study of the Japan Lipid Assessment Program (J-LAP). Current Therapeutic Res 2005; 66:80-95.
 
3) 寺本民生, ALWAYS study group:アトルバスタチン特定使用成績調査 (ALWAYS) 中間解析報告, Therapeutic Research vol. 32, no. 12, 2011.
 
4) 日本動脈硬化学会診療・疫学委員会:動脈硬化性疾患予防ガイドライン2007年版.
 

第11章 呼吸器

P.147 掲載の参考文献
1) Agency for Health Care Research and Quality:AHRQ Quality Indicators Inpatient quality Indicators technical specifications IQI #20 Pneumonia Mortality rate. http://www.qualityindicators.ahrq.gov/Modules/IQI_TechSpec.aspx (2012.05.07 available)
 
2) Agency for Healthcare Research and Quality:AHRQ Quality Indicator:Comparative Data for the IQI based on the 2008 Nationwide Inpatient Sample (NIS). http://www.qualityindicators.ahrq.gov/Downloads/Modules/IQI/V43/Comparative%20 Data%201QI%204.3.pdf (2012.05.07 available)
 
P.149 掲載の参考文献
1) The Joint Commission; Improving America's Hospitals The Joint Commission's Annual Report on Quality and Safety 2011. http://www.jointcommission.org/assets/1/6/TJC_AnnualReport_2011_9_13_11_.pdf (2012.05.28 available)
 
2) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c PN-3b Blood Cultures Performed in the Emergency Department Prior to Initial Antibiotic Received in Hospital http://www.jointcommission.org/assets/1/6/NHQM_v4_0_cpdf-12_29_2011.zip (2012.05.31 available)
 
3) Ann Emerg Med 2005; 46 (5):393-400.
 
P.151 掲載の参考文献
1) Institute for Healthcare Improvement. Implement the IHI Ventilator Bundle. http://www.ihi.org/knowledge/pages/changes/implementtheventilatorbundle.aspx (2012.05.28 available)
 
2) Safdar N, Dezfulian C, Collard HR, et al.:Clinical and economic consequences of ventilator-associated pneumonia:a systematic review. Crit Care Med 2005; 33:2184-2193.
PubMed
3) 日本環境感染学会JHAIS委員会 医療器具関連感染サーベイランス部門サーベイランス結果報告書 2009年4月～2010年9月データサマリー. http://www.kankyokansen.org/modules/iinkai/index.php?content_id=6 (2012.05.28 available)
 
4) Resar R, Pronovost P, Haraden C, et al.:Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Joint Commission J. on Quality and Patient Safety 2005; 31:243-248.2184-2193.
 
5) 日本集中治療医学会人工呼吸関連肺炎予防バンドル2010改訂版. http://www.jsicm.org/pdf/2010VAP.pdf (2012.05.28 available) php?content_d=6 (2012.05.28 available)
 
6) 日本環境感染学会 JHAIS委員会医療器具関連感染サーベイランス部門 サーベイランスに使用する用語と判定の定義. http://www.kankyokansen.org/modules/iinkai/index.php?content_id=6 (2012.05.28 available)
 

第12章 脳・神経

P.155 掲載の参考文献
1) Agency for Healthcare Research and Quality; AHRQ Quality Indicator:Comparative Data for the IQI based on the 2008 Nationwide Inpatient Sample (NIS). http://www.qualityindicators.ahrq.gov/Downloads/Modules/IQI/V43/Comparative%20 Data%20IQI%204.3.pdf (2012.05.07 available)
 
2) Agency for Healthcare Research and Quality; AHRQ Quality indicators Inpatient quality indicators technical specifications IQI #13 Craniotomy Mortality rate. http://www.qualityindicators.ahrq.gov/Modules/IQI_TechSpec.aspx (2012.05.07 available)
 
P.160 掲載の参考文献
1) American Academy of Neurology/American College of Radiology/Physician Consortium for Performance Improvement/ National Committee for Quality Assurance Stroke and Stroke Rehabilitation Work Group; Stroke and Stroke Rehabilitation Physician Performance Measurement Set. http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/stroke-release-notes.pdf (2012.05.31 available)
 
2) The Joint Commission; Improving America's Hospitals The Joint Commission's Annual Report on Quality and Safety 2011. http://www.jointcommission.org/assets/1/6/TJC_Annual_Report_2011_9_13_11_pdf (2012.05.31 available)
 
3) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c STK-2 Discharged on Antithrombotic Therapy. http://www.jointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012.05.31 available)
 
4) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c STK-3 Anticoagulation Therapy for Atrial Fibrillation/Flutter. http://www.jointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012.05.31 available)
 

第13章 心血管

P.165 掲載の参考文献
1) Agency for Healthcare Research and Quality; AHRQ Quality Indicator:Comparative Data for the IQI based on the 2008 Nationwide Inpatient Sample (NIS). http://www.qualityindicators.ahrq.gov/Downbads/Modules/IQI/V43/Comparative%20 Data%201QI%204.3.pdf
 
2) Agency for Healthcare Research and Quality. AHRQ Quality indicators Inpatient quality indicators technical specifications IQI #30 PTCA Mortality rate. http://www.qualityindicators.ahrq.gov/Modules/IQI_TechSpec.aspx (2012.05.21 available)
 
P.166 掲載の参考文献
1) The Joint Commission; Improving America's Hospitals The Joint Commission's Annual Report on Quality and Safety 2011. http://www.jointcommission.org/assets/1/6/TJC_Annual_Report_2011_9_13_11.pdf (2012.05.28 available)
 
2) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c AMI-8a Primary PCI Received Within 90 Minutes of Hospital Arrival. http://wwwJointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012.05.28 available)
 
3) Antman EM, et al.:ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation 2004; 110:82-292.
 
4) Flynn A, et al.:Trends in door-to-balloon time and mortality in patients with STEMI undergoing PPCI. Arch Intern Med 2010; 170:1842-1849.
 
P.171 掲載の参考文献
1) The Joint Commission; Improving America's Hospitals The Joint Commission's Annual Report on Quality and Safety 2011. http://www.jointcommission.org/assets/1/6/TC_Annual_Report_2011_9_13_11_.pdf (2012.05.21 available)
 
2) 循環器病の診断と治療に関するガイドライン (2006). Guidelines for Secondary Prevention of Myocardial lnfarction (JCS 2006). Prevention, (Jcs), 1-52.
 
3) 循環器病の診断と治療に関するガイドライン (2008). Guidelines for the management of patients with ST-elevation myocardial infarction (JCS 2008). Circulation Journal; 72:1347-1442.
 
4) Foresi A, Cavigioli G, Signorelli G, Pozzoni MB, Olivieri D:Is the use of beta-blockers in COPD still an unresolved dilemma? Respiration; international review of thoracic diseases 2010; 80 (3):177-187.doi:10.1159/000318583.
 
5) The Joint Commission; Specifications Manualfor National Hospital Inpatient Quality Measures, Version 4.0c AMI-2 Aspirin Prescribed at Discharge. http://www.jointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012.05.21 available)
 
6) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c AMI-5 Beta-BLocker Prescribed at Discharge. http://www.jointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012.05.21 available)
 
7) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4. 0c AMI-10Statin Prescribed at Discharge. http://www.jointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012.05.21 available)
 
8) Hector MM, Christopher PC, Xin Z, et al.:Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older:Findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD).
 
P.172 掲載の参考文献
1) The Joint Commission; Improving America's Hospitals The Joint Commission's Annual Report on Quality and Safety 2011. http://www.jointcommission.org/assets/1/6/TJC_Annual_Report_2011_9_13_11_.pdf (2012.05.21 available)
 
2) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c AMI-1 Aspirin at Arrival. http://www.jointcommission.org/assets/1/6/NHQM_v4_0_c_pdf_12_29_2011.zip (2012.05.21 available)
 
P.175 掲載の参考文献
1) The Joint Commission; Improving America's Hospitals The Joint Commission's Annual Report on Quality and Safety 2011. http://www.jointcommission.org/assets/1/6/TJC_AnnualReport_2011_9_13_11_.pdf (2012.05.21 available)
 
2) The Joint Commission; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.0c AMI-3 ACEI or ARB for LVSD. http://www.jointcommission.org/assets/1/6/NHQM-v4_0_c_pdf_12_29_2011.zip (2012.05.21 available)
 
3) ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction:A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation 2006, 113:732-761.
 
P.176 掲載の参考文献
1) The Australian Council on Healthcare Standards:ACHS Australasian Clinical Indicator Report:2003-2010 Determining the Potential to Improve Quality of Care:12th Edition. http://www.achs.org.au/pdf/lnternalMedicine_www.pdf (2012.05.31 available)
 
P.179 掲載の参考文献
1) 武藤正樹のwebsite内の講義ファイル. http://masaki.muto.net/class/2006/20060516.pdf
 
2) Pennsylvania's Guide to Coronary Artery Bypass Graft (CABG) Surgery 2000-Statewide Highlights. http://www.phc4.org/reports/cabg/00/statewide.htm
 

第14章 慢性腎臓病

P.182 掲載の参考文献
1) Nissennson AR, Collins AJ, Hurley J et al.:0pportunities for Improving the Care of Patients with Chronic Renal Insufficiency:Current practice patterns, J Am Soc Nephrol 2001; 12:1713-1720.
 
2) Philipneri MD:Delivery patterns of recommended chronic kidney disease care in clinical practice:administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 2008; 12:41-52.
PubMed
P.185 掲載の参考文献
1) 2008年版日本透析医学会:慢性腎臓病患者における腎性貧血治療のガイドライン.
 
2) KDOQI Clinical practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47 (5 Suppl 3):S11-145.
 
3) Centers for Medicare and Medicaid services; Quality Measurement and Health Assessment Group (QMHAG):ESRD-Anemia Management CPM la:Hemoglobin Control for ESA Therapy. http://www.dialysisreports.org/pdf/esrd/public-measures/Hemoglobin_Control_for_ESA_Therapy.pdf (2012.05.31 available)
 
4) United States Renal Data System. 2011 Atlas of CKD & ESRD. Clinical Indicators and Preventive Care. http://www.usrds.org/atlas.aspx (2012.05.31 available)
 
P.186 掲載の参考文献
1) NKF KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations 2006 Updates Hemodialysis Adequacy and Peritoneal Dialysis Adequacy. Am J Kidney Dis 2006:Supple 1.
 
2) Centers for Medicare & Medicaid Services, Department of Health and Human Services; 2008 ANNUAL REPORT ESRD CLINICAL PERFORMANCE MEASURES PROJECT. 0PPORTUNITIES TO IMPROVE CARE FOR IN-CENTER HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS. http://www.esrdnetwork.org/assets/pdf/data/2008cpmannualreport.pdf (2012.05.31 available)
 
3) Centers for Medicare and Medicaid services; Quality Measurement and Health Assessment Group (QMHAG):ESRD-HD Adequacy CPM III:Minimum Delivered Hemodialysis Dose for ESRD hemodialysis patients undergoing dialytic treatment for a period of 6 months or greater. http://www.dialysisreports.org/pdf/esrd/public-measures/Minimum_De_HD_Dose_6_mos.pdf (2012.05.31 available)
 
4) Centers for Medicare and Medicaid services; Quality Measurement and Health Assessment Group (QMHAG):ESRD-PD Adequacy CPM III:Delivered Dose of Peritoneal Dialysis. http://www.dialysisreports.org/pdf/esrd/public-measures/Delivered_Dose_of_PD.pdf (2012.05.31 available)
 

第15章 消化器

P.191 掲載の参考文献
1) 急性胆道炎の診療ガイドライン作成 出版委員会編:科学的根拠に基づく急性胆管炎・胆嚢炎の診療ガイドライン[第1版]. 医学図書出版, 2005.09.
 
2) Keus F, de Jong J, Gooszen HG, Laarhoven CJHM:Laparoscopic versus open Cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.:CD006231. DOI:10.1002/14651858.CD006231.
 
3) Shea JA et al.:Mortality and complications associated with laparoscopic cholecystectomy. A meta-analysis. Ann Surg 1996; 224 (5):609-620.
PubMed
4) NIH Consensus Development Panel on Gallstones and Laparoscopic Cholecystectomy. Journal of the American Medical Association 1993:269 (8):1018-1024. [MEDLINE:1993156112]
 
5) Agency for Healthcare Research and Quality; AHRQ Quality Indicator:Comparative Data for the IQI based on the 2008 Nationwide Inpatient Sample (NIS). http://www.qualityindicators.ahrq.gov/Downloads/Modules/IQI/V43/Comparative%20 Data%20IQI%204.3.pdf (2012.04.17 available)
 
6) Agency for Healthcare Research and Quality. AHRQ Quality indicators Inpatient quality indicators technical specification IQI #23 Laparoscopic Cholecystectomy Rate. http://www.qualityindicators.ahrq.gov/Modules/IQL_TechSpec.aspx (2012.04.17 available)
 
P.192 掲載の参考文献
1) American Medical Association AMA-PCPI Quality measures. http://www.ama-assn.org/apps/listserv/x-check/qmeasure.cgi?submit=PCPI (2012.05.09 available)
 

第16章 眼・耳鼻咽喉

P.196 掲載の参考文献
1) The Australian Council on Healthcare Standards:ACHS Australasian CLinical Indicator Report:2003-2010 Determining the Potential to Improve Quality of Care:12th Edition. http://www. achs.org.au/pdf/Ophthalmology_www.pdf (2012.05.09available)
 
P.197 掲載の参考文献
1) Rosenfeld RM, et al.:Clinical practice guideline:acute otitis externa. Otolaryngol Head Neck Surg 2006; 134 (4 Suppl):S4-23.
 
2) Richard M, et al.:Systemic review of topical antimicrobial therapy for acute otitis externa. Otolaryngol Head Neck Surg 2006; 134 (1 Suppl):S24-48.
 
3) AOE/0ME Work Group American Academy of Otolaryngology Head and Neck Surgery (AAO-HNS) Foundation/Physician Consortium for Performance Improvement(R) (PCPI); Acute Otitis Externa (AOE)/Otitis Media with Effusion (0ME) Physician Performance Measurement Set. http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/acute-otitis-externa-otitis-media-worksheets.pdf (2012.05.09 available)
 
P.199 掲載の参考文献
1) Rosenfeld RM, et al.:Clinical practice guideline:Otitis media with effusion. Otolaryngol Head Neck Surg 2004; 130 (5 Suppl):S95-118.
 
2) AOE/0ME Work Group American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Foundation/Physician consortium for Performance Improvement (PCPI); Acute Otitis Externa (AOE) /Otitis Media with Effusion (OME) Physician Performance Measurement Set. http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/acute-otitis-externa-otitis-media-worksheets.pdf (2012.05.09 available)
 

第17章 救急

P.204 掲載の参考文献
1) Agency for Healthcare Research and Quality; 2009 National Healthcare Quality & Disparities Reports. hhtp://www.ahrq.gov/qual/qrdr09/13_timeliness/T13_2_1-1.htm (2012.06.04 available)
 
2) Agency for Healthcare Research and Quality; National Healthcare Quality and Disparities Reports, 2009 Measure Specifications Waiting Time. http://www.ahrq.gov/qual/qrdr09/measurespec/timeliness.htm#wtimmt1 (2012.06.04 available)
 
P.208 掲載の参考文献
1) 25米国小児専門病院 (Pediatric Emergency Care Applied Network, Lancet 2009; 374:1160) .
 
2) 日本の一般病院 (藤沢市民病院:2011年小児救急学会発表, *NICE ガイドラインを導入).
 
3) Brenner DJ, Hall EJ:Computed Tomography-An lncreasing Source of Radiation Exposure. N Engl J Med 2007; 357:2277-2284.
PubMed
4) Stiell IR, et al.:The Canadian CT Head Rule for patients with minor head injury. Lancet 2001; 357:1391-1396.
 
5) Smits M, et al.:External Validation of the Canadian CT Head Rule and the New 0rleans Criteria for CT Scanning in Patients With Minor Head Injury. JAMA 2005; 294:1519-1525.
 
6) Kuppermann N, et al:Identification of Children at very low risk of clinically-important brain injuries after head trauma:a prospective cohort study. Lancet 2009; 374:1160-1170.
PubMed
7) Patricia C, et al.:Should a Head-lnjured Child Receive a Head CT Scan? A Systematic Review of Clinical Prediction Rules. Pediatrics 2009; 124:e145-e154.
 
8) Oman JA, et al.:Performance of a Decision Rule to Predict Need for computed Tomography Among Children With Blunt Head Trauma. Pediatrics 2006; 117; e238-e246.
PubMed
9) Bulas D, et al.:Image Gently:improving health literacy for parents about CT scans for children. Pediatr Radiol 2009; 39:112-116.
PubMed

第18章 腫瘍

P.213 掲載の参考文献
1) Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, et al.:American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol 2008; 26(21):3631-3637. http://jco.ascopubs.org/ccgi/content/abstract/26/21/3631 (2012.05.08 available)
 
2) American Society of Clinical Oncology (ASCO)/National Comprehensive Cancer Network (NCCN) Quality Measures:Breast and Colorectal Cancers. April 2007. http://www.asco.org/ASCO/Downloads/Cancer%20Policy%20and%20Clinical%20Affairs/NCCN/ASCO%20NCCN%20Quality%20Measures%20table%20web%20posting%20with%20CoC%200507.pdf (2012.05.08 available)
 
3) Darby S, McGate P, Correa C, Taylor C, Arriagada R, Clarke M, et al.:Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death:meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011; 378(9804):1707-1716.
 
4) Hughes KS, Schnaper LA, Cirrincione C, Berry D, McCormick B, Muss HB, et al.:Lumpectomy plus tamoxifen with or without irradiation in women 70 rr older with ealy breast cancer. J Clin Oncol 2010; 28:15s, (suppl; abstr 507).
 
P.214 掲載の参考文献
1) American Medical Association AMA-PCPI Quality measures. http://www.ama-assn.org/apps/listserv/x-check/qmeasure.cgi?submit=PCPI (2012/04/18 available)
 
2) 大腸癌治療ガイドライン 医師用 2010年版 大腸癌研究会編
 
3) Van Cutsem E, Oliveira J; ESMO Working Group:Colon Cancer:ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2008:19 (Supplement 2):ii29-ii30.
 
4) Andre T, et al. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients:final results of GERCOPR C96.1. J Clin Oncol 2007; 25:3732.
PubMed
5) National Institute of Health Consensus conference. Adjuvant therapy for patients with colon and rectal cancer. J Am Med Assoc 1990; 264:1444-1450.
 
6) Lembersky BC, et al.:0ral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon:result from National Surgical Adjuvant Breast and Bowel Project protocol C-06. J Clin Oncol 2006; 24:2059-2064.
 
7) Andre T, et al.:Oxaliptatin, fluorouracil and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350:2343-2351.
PubMed
8) NIH Consensus Conference:Adjuvant therapy for patients with Colon and rectal Cancer. JAMA 1990; 264:1444-1450.
PubMed
9) Wolmark N, Rockette H, Fisher B, et al.:The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer:Results from National Surgical Adjuvant Breast and Bowel Project Protocol C-03. J Clin Oncol 1993; 11:1879-1887.
PubMed
P.217 掲載の参考文献
1) 診療の質指標 Quality Indicatorがん対策における管理評価指標群の策定とその計測システムの確立に関する研究班 http://qi.ncc.go.jp/index.html (2012.04.18 available)
 
2) 胃癌診療ガイドライン 医師用 2010年10月改訂 日本胃癌学会編
 
3) Sakuramoto S, et al.:Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357:1810-1820.
 
P.218 掲載の参考文献
1) Parsons HM, et al.:Clinical trial participation and time to treatment among adolescents and young adults with cancer:Does age at diagnosis or insurance make a difference? J Clin Oncol 2011; 29:4045-4053,
PubMed
2) Bleyer A, et al.:Adolescents and young adults with cancer. The scope of the problem and criticality of clinical trials. Cancer 2006; 107 (7 Suppl):1645-1655.
 
3) SNational Cancer Institute; Surveillance Epidemiology and End Results. http://seer.cancer.gov/csr/1975_2009_pops09/index.html (2012.05.30 available)
 

第19章 地域連携

P.223 掲載の参考文献
1) 田島誠一, 高橋淑郎:病院管理. 建帛社, 2012.
 
2) 第1回特定機能病院及び地域医療支援病院のあり方に関する検討会資料 http://www.mhlw.go.jp/stf/shingi/2r985200000253pdatt/2r985200000253tc.pdf
 

書評

最近チェックした商品履歴

Loading...